Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Panacea Biotec

BSE: 531349|NSE: PANACEABIO|ISIN: INE922B01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 25, 16:00
255.65
1.4 (0.55%)
VOLUME 25,909
LIVE
NSE
May 25, 15:50
255.40
1.5 (0.59%)
VOLUME 48,917
Announcements on Panacea Biotec

16th-May-2018 17:04Source: BSE

Panacea Biotec- Board Meeting On 30Th May, 2018 For Approving The Audited Financial Results For The Quarter / Financial Year Ended 31St March, 2018

Pursuant to Reg.29 of the SEBI Listing Regulations,2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 30.05.2018 at New Delhi, int...

18th-Apr-2018 15:16Source: BSE

Panacea Biotec- Shareholding for the Period Ended March 31, 2018

Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly

9th-Apr-2018 14:48Source: BSE

Panacea Biotec- Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 For The Half-Year Ended On 31St March, 2018

Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 for the half-year ended on 31st March, 2018

9th-Apr-2018 14:43Source: BSE

Panacea Biotec- Statement Of Investor Complaints For The Quarter Ended March 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complai...

1st-Apr-2018 09:11Source: BSE

Panacea Biotec- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Soshil Kumar Jain

1st-Apr-2018 09:09Source: BSE

Panacea Biotec- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Soshil Kumar Jain

28th-Mar-2018 16:48Source: BSE

Panacea Biotec- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Serum Institute of India Pvt Ltd

13th-Mar-2018 16:47Source: BSE

Panacea Biotec- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunanda Jain

13th-Mar-2018 16:26Source: BSE

Panacea Biotec- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunanda Jain

12th-Mar-2018 15:43Source: BSE

Panacea Biotec- Board Meeting-Outcome of Board Meeting

We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 12th March, 2018, inter-alia, considered and approved the following to be effective from 12t...

1 2 3 4 5 Next >>
Board Meeting (Panacea Biotec)

Meeting Date

Remark

2018-05-30

Audited Results

Quick Links for Panacea Biotec
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.